255 related articles for article (PubMed ID: 8939636)
1. Therapeutic targeting of the p53 tumor suppressor gene.
Beaudry GA; Bertelsen AH; Sherman MI
Curr Opin Biotechnol; 1996 Dec; 7(6):592-600. PubMed ID: 8939636
[TBL] [Abstract][Full Text] [Related]
2. Restoration of wild-type p53 function in human tumors: strategies for efficient cancer therapy.
Wiman KG
Adv Cancer Res; 2007; 97():321-38. PubMed ID: 17419952
[TBL] [Abstract][Full Text] [Related]
3. Advances in adenovirus-mediated p53 cancer gene therapy.
Tazawa H; Kagawa S; Fujiwara T
Expert Opin Biol Ther; 2013 Nov; 13(11):1569-83. PubMed ID: 24107178
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in p53 research and cancer treatment.
Suzuki K; Matsubara H
J Biomed Biotechnol; 2011; 2011():978312. PubMed ID: 21765642
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic targeting of tumor suppressor genes.
Morris LG; Chan TA
Cancer; 2015 May; 121(9):1357-68. PubMed ID: 25557041
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applications.
Horowitz J
Curr Opin Mol Ther; 1999 Aug; 1(4):500-9. PubMed ID: 11713766
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of action of the p53 tumor suppressor and prospects for cancer gene therapy by reconstitution of p53 function.
Roemer K; Friedmann T
Ann N Y Acad Sci; 1994 May; 716():265-80; discussion 280-2. PubMed ID: 8024199
[No Abstract] [Full Text] [Related]
8. To pop or not to pop: p53 as a critical modulator of tumour responsiveness to therapy in vivo?
Workman P
Hum Exp Toxicol; 1995 Feb; 14(2):222-5. PubMed ID: 7779451
[No Abstract] [Full Text] [Related]
9. New p53-based anti-cancer therapeutic strategies.
Wiman KG
Med Oncol; 1998 Dec; 15(4):222-8. PubMed ID: 9951684
[TBL] [Abstract][Full Text] [Related]
10. Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies.
Harris CC
J Natl Cancer Inst; 1996 Oct; 88(20):1442-55. PubMed ID: 8841019
[TBL] [Abstract][Full Text] [Related]
11. The p53 tumour suppressor gene.
Steele RJ; Thompson AM; Hall PA; Lane DP
Br J Surg; 1998 Nov; 85(11):1460-7. PubMed ID: 9823903
[TBL] [Abstract][Full Text] [Related]
12. The p53 tumour suppressor protein.
Hickman ES; Helin K
Biotechnol Genet Eng Rev; 2000; 17():179-211. PubMed ID: 11255666
[No Abstract] [Full Text] [Related]
13. Structural biology of the tumor suppressor p53 and cancer-associated mutants.
Joerger AC; Fersht AR
Adv Cancer Res; 2007; 97():1-23. PubMed ID: 17419939
[TBL] [Abstract][Full Text] [Related]
14. Biological and clinical importance of the p53 tumor suppressor gene.
Velculescu VE; El-Deiry WS
Clin Chem; 1996 Jun; 42(6 Pt 1):858-68. PubMed ID: 8665676
[TBL] [Abstract][Full Text] [Related]
15. Targeting p53 in cancer.
Chène P
Curr Med Chem Anticancer Agents; 2001 Aug; 1(2):151-61. PubMed ID: 12678764
[TBL] [Abstract][Full Text] [Related]
16. [Role of the p53 and bcl-2 genes in apoptosis and drug resistance of tumors].
Luk'ianova NIu; Kulik GI; Chehun VF
Vopr Onkol; 2000; 46(2):121-8. PubMed ID: 10853407
[No Abstract] [Full Text] [Related]
17. p53 and human cancers.
Lane DP
Br Med Bull; 1994 Jul; 50(3):582-99. PubMed ID: 7987642
[TBL] [Abstract][Full Text] [Related]
18. Unique strategy restores p53 function in mice.
Bucci M
J Natl Cancer Inst; 2004 Apr; 96(8):581. PubMed ID: 15100333
[No Abstract] [Full Text] [Related]
19. Achilles' heel of cancer?
Vogelstein B; Kinzler KW
Nature; 2001 Aug; 412(6850):865-6. PubMed ID: 11528457
[No Abstract] [Full Text] [Related]
20. p53 as the Focus of Gene Therapy: Past, Present and Future.
Valente JFA; Queiroz JA; Sousa F
Curr Drug Targets; 2018; 19(15):1801-1817. PubMed ID: 29336259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
